Use access key #2 to skip to page content.
$58.07 -0.79 (-1.34%)
8/20/2008 3:08 PM

Abbott Laboratories (ABT)

CAPS Rating:
****

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

View Ticker Page (ABT)

Results 31 - 40 of 126 :   12345Next »

Recs

0

Avatar slade15342 (94.52) Submitted: 2/22/08 9:08 PM : Outperform Start Price: $54.06 ABT Score: 13.51

Major upside. Arthritis drugs are booming, new wave stents could revolutionize the market, especially in the US where everyone overeats and has heart problems. Good value and a solid track record with dips only on the major recession lines. 2008 s...

Report this Post Replies: 1 | Reply | Permalink

Recs

0

Avatar wgkoch (51.85) Submitted: 2/27/08 12:50 PM : Outperform Start Price: $54.15 ABT Score: 15.52

Stents from Guidant deal...now improved...seem still a better alternative than dying, you think?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar bigsur1 (62.06) Submitted: 3/10/08 7:49 PM : Outperform Start Price: $50.10 ABT Score: 18.54

Solid company with excellent payout record in dividends

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar DrDe1167 (51.81) Submitted: 3/12/08 10:32 PM : Outperform Start Price: $50.59 ABT Score: 16.58

Strong but narrow pipeline of new drugs. Expectation is 30%-35% in the next year assuming economy stays relatively stagnant. If economic window brightens ABT will fall a little but still maintain steady growth in the 20%-25% range.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar hosseinh (48.50) Submitted: 3/17/08 1:36 AM : Outperform Start Price: $49.61 ABT Score: 16.49

A wonderful company with an exciting and packed pipe line. Has contract with many smaller and bigger companies and many joint vetures. However, it is the pipe line that matters the most to me...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar wolfhounds (66.49) Submitted: 3/17/08 11:32 AM : Outperform Start Price: $51.69 ABT Score: 12.65

Humira sales, and quality pipeline have potential for increasing worldwide for a number of years. Consumer business is a nice cash cow.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar bobbob12345 (< 20) Submitted: 2/13/08 12:04 PM : Outperform Start Price: $55.34 ABT Score: 11.43

it has a cool name qa good sdtockand it could make some money

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar josh8dtb (< 20) Submitted: 4/24/08 4:34 PM : Outperform Start Price: $50.46 ABT Score: 23.75

This stock has a good dividend and is near its 52 week low. Given time it will exceed S&P 500.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar richardrogers4 (48.61) Submitted: 6/08/08 11:41 AM : Outperform Start Price: $54.88 ABT Score: 12.95

- Limited near term patent exposure
- Diversified

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar PerfectYourCraft (57.96) Submitted: 6/12/08 10:38 PM : Outperform Start Price: $53.84 ABT Score: 13.23

Good company.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners